Table 1
Updated March 16, 2015 | Retrsopective Cohort (2007-2012)N=97, 11 sites | Prospective Cohort (2011-2015)N=311, 39 sites |
mOS, months | 48 | NR |
Median follow-up, months | 43.8 | 18.7 |
1,2,3 year survival rate, CP/PR | 100%, 89%, 84% | 100%, 85%, 79% |
1,2,3 year survival rate, SD | 89%, 69%, 61% | 95%, 76%, n/d |
ORR | 20% (CR: 5%, PR: 15%) | 16% (CR: 3%, PR: 13%) |
CR+PR+SD | 49% | 55% |
mOS no prioir TT/prior TT | 48.9 (n=82)/15.3 (n=15) | NR (n=266)/22.1 (n=45) |